`G2077` Periodic assessment

Periodic assessment; assessing periodically by an otp practitioner and includes a review of moud dosing, treatment response, other substance use disorder treatment needs, responses and patient-identified goals, and other relevant physical, nutrition and psychiatric treatment needs and goals; may be informed by administration of a standardized, evidence-based assessment, or the need and interest for harm reduction interventions and recovery support services (provision of the services by a medicare-enrolled opioid treatment program); list separately in addition to each primary code

Medicare coverage: Carrier judgment
Status: active (October 2026 file)

Medicare pricing for G2077

Physician Fee Schedule (CY 2026, RVU26D)

Status X: statutory exclusion, not paid under the PFS.

Payer policies and prior authorization for G2077

Payer coverage policies that name G2077

G2077 appears in 1 coverage policy from Blue Cross & Blue Shield of Rhode Island.

Payer	Policy	Role in policy	Reviewed	Document
Blue Cross & Blue Shield of Rhode Island	Opioid Treatment Program MEDICAL COVERAGE POLICY \| 2	covered if criteria are met		payer document

Medicaid fee-for-service

IN: $94.49 (professional, Advanced Practice Nurse (85%), non-facility), effective Jul 1, 2023
KS: $98.76 (default), effective Jan 1, 2026
MS: $126.49 (comprehensive), effective Jul 1, 2026
ND: $147.93 (physician), effective Aug 1, 2026
VT: $0.00 (outpatient_hospital_opps), effective Feb 1, 2026
WY: $0.00 (outpatient_hospital_apc, Children's Hospitals), effective Apr 1, 2026

From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.

G2077 Periodic assessment